Umang Vohra has stepped down as the Managing Director (MD) and Global Chief Executive Officer (CEO) of Cipla, with Achin Gupta taking the charge from 1 April 2026.
Gupta has been serving as Global Chief Operating Officer at Cipla since February 2025, overseeing commercial markets, active pharmaceutical ingredients (API), manufacturing and supply chain operations. He joined the company in 2021 as Chief Executive Officer of its One India business and has been part of the management council.
He has driven strong growth, expanded Cipla’s reach in chronic therapies and underserved geographies, and strengthened its core operations. Under his leadership, the India business delivered market leading profitability, modernised its retail force, and introduced consumer-focused innovations. Gupta also forged strategic global partnerships, positioning Cipla as a preferred innovation-led collaborator.
Before joining Cipla, Gupta worked with Glenmark Pharmaceuticals, Abbott, and AT Kearney. He has deep expertise in healthcare across India, UK, Europe, Latin America, Asia, Middle East.
